A number of analysts have tweaked their price targets for shares of Dollar General following the company’s second-quarter profit report, which investors met with a good bit of antipathy. Most of the Street moves so far have been positive, though: Scott Ciccarelli at RBC Capital has taken his target to $88 from $86 — Dollar General (Ticker: DG) is changing hands this morning around $74 — and Matt Boss at JPMorgan Chase is even more upbeat, having taken his target to $90 from $87.
Paul Trussell at Deutsche Bank is a little less upbeat — even though he is keeping his ‘buy’ rating — and has tweaked his target to $84 from $85. And Meredith Adler at Barclays is even less optimistic. She has an ‘equal weight’ rafting on Dollar General and, with a $76 target (up from $74), still sees the stock going nowhere for a while.
Stifel Nicolaus analyst Dan Bernstein has upgraded shares of Healthcare Realty Trust to 'buy' from 'hold,' saying the Nashville-based REIT is a good value for investors to step in after it slipped from above to $25 to below $23 in the recent market swoon. Bernstein sees more than 20 percent upside for Healthcare Realty (Ticker: HR), which was changing hands at almost $23.20 Wednesday afternoon. Read more here.
Shareholders of Noranda Aluminum Holding on Monday voted overwhelmingly to approve a 1-for-7 reverse stock split, part of the company's plan to get back in the good graces of the New York Stock Exchange's listing standards panel. Noranda shares (Ticker: NOR) should this morning begin trading around $2.60. Its leaders also must still find ways to boost the Franklin-based company's shareholder's equity above $50 million.
POSTDATA: WARRANTY DEEDS